Press "Enter" to skip to content

Cyteir Therapeutics Announces New Data Demonstrating Lead Compound CYT-0851 is Active Against Lymphomas and Solid Tumors, Synergistic with PARP Inhibitors – BioSpace

admin 0

Cyteir Therapeutics Announces New Data Demonstrating Lead Compound CYT-0851 is Active Against Lymphomas and Solid Tumors, Synergistic with PARP Inhibitors  BioSpace

Published: Mar 31, 2019. Novel, targeted, oral drug candidate inhibits DNA-repair protein to induce cell death in multiple cancer types including pancreatic …

“lymphoma cancer” – Google News

(Visited 11 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *